Regulatory challenges and current policy for cardiotoxicity detection in oncology drug development.

Journal: Journal of thrombosis and thrombolysis •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Becker RC (2026). "Regulatory challenges and current policy for cardiotoxicity detection in oncology drug development.". Journal of thrombosis and thrombolysis. https://doi.org/10.1007/s11239-026-03337-w